Tamar Bridge News is your trusted guide through the currents of UK news, committed to bridging the gap between information and insight with clarity, precision, and a human-centric approach.
BeiGene, Ltd., a global oncology company, has announced the passing of Donald Glazer, a cherished member of its board and chair of the nominating and corporate governance committee. His death has elicited a profound sense of loss within the organisation, which he helped establish in 2010. John V. Oyler, Co-founder, Chairman, and CEO of BeiGene, expressed his sorrow in a heartfelt statement. “We are saddened by the passing of our dear friend, Don Glazer. He played an instrumental role in the founding of the company and was a steadfast supporter of our mission to provide innovative medicines to patients worldwide…